Catalyst Wire Dossier Catalyst Wire Dossier

Radium Ra-223

radium-223 dichloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Radium Ra-223, covering 2019-05-21 to 2019-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer [Phase 2]

See pricing